.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
McKesson
QuintilesIMS
Farmers Insurance
Covington
Harvard Business School
Dow
Moodys
Federal Trade Commission
AstraZeneca

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084427

« Back to Dashboard

NDA 084427 describes DILANTIN, which is a drug marketed by Parke-davis, Parke Davis, and Pfizer, and is included in four NDAs. It is available from ten suppliers. Additional details are available on the DILANTIN profile page.

The generic ingredient in DILANTIN is phenytoin. There are nineteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the phenytoin profile page.

Summary for 084427

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 084427

Suppliers and Packaging for NDA: 084427

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DILANTIN phenytoin TABLET, CHEWABLE;ORAL 084427 ANDA Parke-Davis Div of Pfizer Inc 0071-0007 0071-0007-40 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0071-0007-40) > 1 TABLET, CHEWABLE in 1 BLISTER PACK
DILANTIN phenytoin TABLET, CHEWABLE;ORAL 084427 ANDA Parke-Davis Div of Pfizer Inc 0071-0007 0071-0007-24 100 TABLET, CHEWABLE in 1 BOTTLE (0071-0007-24)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, CHEWABLE;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Healthtrust
McKinsey
Baxter
Boehringer Ingelheim
Queensland Health
Moodys
Fuji
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot